Dr. Paul W Finnegan
Institution Name:
Total Awards:
1
Award Value:
$3,797,117
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Late Stage Preclinical Projects | Angiocrine Bioscience, Inc. | Development of AB-110: genetically-modified endothelial cells plus expanded cord blood hematopoietic stem cells as a transplantation therapy | $3,797,117 |
| Total: $3,797,117.00 |
